The Corrective Managed Care (CMC) Program has been instituted by the Maryland Medicaid Pharmacy program to monitor and promote appropriate use of controlled substances.  

The CMC program is particularly concerned with the prescribing practices and utilization of opioids and benzodiazepines. Through a monthly review mandated by OBRA ’90, the state identifies Maryland Medicaid recipients who appear to be on duplicate drug therapy, visit multiple prescribers writing for similar medications, and/or patronize multiple pharmacies. The CMC program shares this information about potential drug misuse with the respective recipient prescribers and pharmacy providers.  

Physicians and pharmacies are asked to intervene. If despite the best efforts of the presciber and pharmacy, there still continues to be overutilization of a substance by a recipient, a recipient can be “locked-in.”. Under a Lock-In pharmacy agreement, the recipient will be required to fill the related medications at one predetermined pharmacy.  To recommend candidates, complete the Recipient Lock-In Referral Form.  

The ultimate goal of locking in a recipient and of the CMC program is to ensure that recipients have access to medication they need while reducing the harm associated with overutilizing controlled substances.